Categories: News

WLFI Partners with AB to Deploy the USD1 Stablecoin on AB Chain

SINGAPORE, Nov. 13, 2025 /PRNewswire/ — World Liberty Financial (WLFI) and AB Chain announced a collaboration under which USD1 has been deployed on AB Chain. Leveraging AB Chain’s high-performance network, USD1 delivers a faster and more convenient stablecoin experience for users.

- Advertisement -

The partnership further enriches AB Chain’s DeFi and payments ecosystem, strengthening use cases across trading, lending, and liquidity.

- Advertisement -

Meanwhile, the decentralized wallet AB Wallet aims to be the most user-friendly wallet for USD1 with zero-fee transfers, near-instant settlement, and full compatibility with all chains where USD1 is available. Looking ahead, AB Wallet is exploring USD1 yield and other value-added services.

- Advertisement -

The launch of USD1 marks an important step forward in AB Chain’s stablecoin infrastructure.

- Advertisement -

Learn more:
WLFI: www.worldlibertyfinancial.com
WLFI official X (Twitter): https://x.com/worldlibertyfi
AB DAO: www.ab.org
AB DAO official X (Twitter): https://x.com/ABDAO_Global
AB Charity Foundation: www.abfdn.org

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/wlfi-partners-with-ab-to-deploy-the-usd1-stablecoin-on-ab-chain-302614449.html

- Advertisement -

Recent Posts

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

8 hours ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

8 hours ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

8 hours ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

8 hours ago

ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract…

8 hours ago

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast…

8 hours ago